Massachusetts Financial Services CO Collegium Pharmaceutical, Inc Transaction History

Massachusetts Financial Services CO

$320 Billion
Q3 2024

A detailed history of Massachusetts Financial Services CO transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Massachusetts Financial Services CO holds 765,692 shares of COLL stock, worth $25 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

765,692

Previous 649,365 17.91%

Holding current value

$25 Million

Previous $20.9 Million 41.5%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$31.4 - $39.07 $3.65 Million - $4.54 Million	116,327 Added 17.91%	765,692 $29.6 Million
Q2 2024 Aug 09, 2024	SELL	$31.36 - $39.99 $389,898 - $497,195	-12,433 Reduced 1.88%	649,365 $20.9 Million
Q1 2024 May 14, 2024	SELL	$31.23 - $40.91 $103,683 - $135,821	-3,320 Reduced 0.5%	661,798 $25.7 Million
Q4 2023 Feb 08, 2024	BUY	$21.16 - $30.8 $12,674 - $18,449	599 Added 0.09%	665,118 $20.5 Million
Q3 2023 Nov 08, 2023	BUY	$21.23 - $24.28 $24,117 - $27,582	1,136 Added 0.17%	664,519 $14.9 Million
Q2 2023 Aug 09, 2023	SELL	$21.06 - $24.0 $128,550 - $146,496	-6,104 Reduced 0.91%	663,383 $14.3 Million
Q1 2023 May 10, 2023	SELL	$23.0 - $29.88 $3.45 Million - $4.49 Million	-150,125 Reduced 18.32%	669,487 $16.1 Million
Q4 2022 Feb 13, 2023	BUY	$16.14 - $23.55 $43,352 - $63,255	2,686 Added 0.33%	819,612 $19 Million
Q3 2022 Nov 09, 2022	SELL	$15.46 - $20.1 $825,254 - $1.07 Million	-53,380 Reduced 6.13%	816,926 $13.1 Million
Q2 2022 Aug 09, 2022	BUY	$14.22 - $20.88 $78,551 - $115,341	5,524 Added 0.64%	870,306 $15.4 Million
Q1 2022 May 11, 2022	BUY	$17.2 - $22.5 $385,297 - $504,022	22,401 Added 2.66%	864,782 $17.6 Million
Q4 2021 Feb 10, 2022	BUY	$17.5 - $21.35 $361,095 - $440,535	20,634 Added 2.51%	842,381 $15.7 Million
Q3 2021 Nov 10, 2021	SELL	$17.75 - $25.39 $191,824 - $274,389	-10,807 Reduced 1.3%	821,747 $16.2 Million
Q2 2021 Aug 13, 2021	BUY	$21.74 - $25.28 $4.11 Million - $4.78 Million	189,232 Added 29.41%	832,554 $19.7 Million
Q1 2021 May 13, 2021	SELL	$19.25 - $26.1 $316,027 - $428,483	-16,417 Reduced 2.49%	643,322 $15.2 Million
Q4 2020 Feb 12, 2021	BUY	$17.83 - $22.29 $177,230 - $221,562	9,940 Added 1.53%	659,739 $13.2 Million
Q3 2020 Nov 12, 2020	SELL	$15.78 - $20.82 $270,137 - $356,417	-17,119 Reduced 2.57%	649,799 $13.5 Million
Q2 2020 Aug 11, 2020	BUY	$15.49 - $23.51 $2.84 Million - $4.31 Million	183,352 Added 37.92%	666,918 $11.7 Million
Q1 2020 May 14, 2020	SELL	$13.89 - $25.45 $146,845 - $269,057	-10,572 Reduced 2.14%	483,566 $7.9 Million
Q4 2019 Feb 13, 2020	SELL	$10.7 - $22.24 $1.01 Million - $2.09 Million	-94,007 Reduced 15.98%	494,138 $10.2 Million
Q3 2019 Nov 05, 2019	SELL	$10.16 - $13.28 $22,829 - $29,840	-2,247 Reduced 0.38%	588,145 $6.75 Million
Q2 2019 Aug 14, 2019	BUY	$10.62 - $16.59 $36,639 - $57,235	3,450 Added 0.59%	590,392 $7.76 Million
Q1 2019 May 13, 2019	SELL	$13.58 - $18.72 $1.04 Million - $1.43 Million	-76,556 Reduced 11.54%	586,942 $8.89 Million
Q4 2018 Feb 08, 2019	BUY	$14.78 - $19.68 $205,057 - $273,040	13,874 Added 2.14%	663,498 $11.4 Million
Q3 2018 Oct 25, 2018	BUY	$14.16 - $24.3 $3.26 Million - $5.59 Million	229,968 Added 54.8%	649,624 $9.58 Million
Q2 2018 Jul 30, 2018	BUY	$21.79 - $28.29 $126,774 - $164,591	5,818 Added 1.41%	419,656 $10 Million
Q1 2018 May 04, 2018	SELL	$18.15 - $29.21 $643,000 - $1.03 Million	-35,427 Reduced 7.89%	413,838 $10.6 Million
Q4 2017 Feb 14, 2018	SELL	$9.3 - $19.14 $2.08 Million - $4.28 Million	-223,362 Reduced 33.21%	449,265 $8.29 Million
Q3 2017 Nov 14, 2017	BUY	$9.15 - $11.97 $37,231 - $48,705	4,069 Added 0.61%	672,627 $7.06 Million
Q2 2017 Aug 14, 2017	BUY	N/A	668,558	668,558 $8.36 Million

Others Institutions Holding COLL

# of Institutions

249

Shares Held

36.2M

Call Options Held

100K

Put Options Held

21.1K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.11B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account

Massachusetts Financial Services CO Collegium Pharmaceutical, Inc Transaction History